• Explore /
  • Poster
  • / <em>MTHFR</em><span> polymorphisms and neurotoxicity and overall survival after methotrexate-based therapy in primary CNS lymphoma.</span>

MTHFR polymorphisms and neurotoxicity and overall survival after methotrexate-based therapy in primary CNS lymphoma.

Abstract Poster

Authors

null

Philipp Karschnia

Department of Neurosurgery, Ludwig-Maximilians-University, Munich, Germany

Philipp Karschnia , Sylvia C. Kurz , Priscilla Kaliopi Brastianos , Sebastian F. Winter , Amanda Gordon , SooAe Jones , Michelle Pisapia , Naema Nayyar , Joerg Tonn , Tracy Batchelor , Scott Randall Plotkin , Jorg Dietrich

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Primary CNS Tumors–Non-Glioma

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 2079)

DOI

10.1200/JCO.2023.41.16_suppl.2079

Abstract #

2079

Poster Bd #

436

Abstract Disclosures

Similar Posters

Poster

2015 ASCO Annual Meeting

Long-term survival in patients with primary CNS lymphoma: Results from the G-PCNSL-SG1 trial.

Long-term survival in patients with primary CNS lymphoma: Results from the G-PCNSL-SG1 trial.

First Author: Patrick Roth

First Author: Jon Glass

First Author: Elisa María Fernández Pérez

First Author: Colin P Bergstrom